Guardant Health Inc (NASDAQ: GH) is 40.39% higher on its value in year-to-date trading and has touched a low of $15.81 and a high of $50.89 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GH stock was last observed hovering at around $40.64 in the last trading session, with the day’s gains setting it 2.25%.
Currently trading at $42.89, the stock is 0.24% and 0.90% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.76 million and changing 5.54% at the moment leaves the stock 34.51% off its SMA200. GH registered 125.86% gain for a year compared to 6-month gain of 72.46%. The firm has a 50-day simple moving average (SMA 50) of $42.5084 and a 200-day simple moving average (SMA200) of $31.88685.
The stock witnessed a -5.49% loss in the last 1 month and extending the period to 3 months gives it a 20.71%, and is 9.08% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.58% over the week and 7.45% over the month.
Guardant Health Inc (GH) has around 2021 employees, a market worth around $5.29B and $739.02M in sales. Profit margin for the company is -59.05%. Distance from 52-week low is 171.28% and -15.72% from its 52-week high. The company has generated returns on investments over the last 12 months (-37.39%).
The EPS is expected to grow by 19.11% this year.
Guardant Health Inc (GH) Top Institutional Holders
425.0 institutions hold shares in Guardant Health Inc (GH), with institutional investors hold 103.26% of the company’s shares. The shares outstanding are 123.99M, and float is at 118.00M with Short Float at 6.69%. Institutions hold 98.39% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 11.64 million shares valued at $336.07 million. The investor’s holdings represent 9.5609% of the GH Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.24 million shares valued at $324.55 million to account for 9.2332 of the shares outstanding. The other top investors are BAILLIE GIFFORD & CO which holds 6.09 million shares representing 4.9763% and valued at over $175.97 million, while DEEP TRACK CAPITAL, LP holds 3.6751 of the shares totaling 4.5 million with a market value of $129.96 million.
Guardant Health Inc (GH) Insider Activity
The most recent transaction is an insider sale by Joyce Meghan V., the company’s Director. SEC filings show that Joyce Meghan V. sold 100 shares of the company’s common stock on Mar 03 ’25 at a price of $42.71 per share for a total of $4271.0. Following the sale, the insider now owns 7647.0 shares.
Still, SEC filings show that on Feb 20 ’25, Tariq Musa (Director) disposed off 116 shares at an average price of $48.33 for $5606.0. The insider now directly holds 3,078 shares of Guardant Health Inc (GH).
